The predictive value of urinary N-acetyl-beta-D-glucosaminidase in evaluating aminoglycoside nephrotoxicity.
D000118:Acetylglucosaminidase / Q000652:urine*; D000328:Adult; D000368:Aged; D000583:Amikacin / Q000009:adverse effects*; D000617:Aminoglycosides / Q000009:adverse effects; D005260:Female; D005839:Gentamicins / Q000009:adverse effects*; D006596:Hexosaminidases / Q000652:urine*; D006801:Humans; D007612:Kanamycin / Q000031:analogs & derivatives*; D007668:Kidney / Q000187:drug effects*; D007674:Kidney Diseases / Q000139:chemically induced*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy / Q000201:enzymology; D008297:Male; D008875:Middle Aged
D000617:Aminoglycosides; D005839:Gentamicins; D007612:Kanamycin; D000583:Amikacin; D006596:Hexosaminidases; D000118:Acetylglucosaminidase